Editas Medicine (United States)
Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Editas Medicine (United States), United States, covering academic research published from 2012 to 2024. Read More.
Open Access Percentage
64%
Total
Publications
152
Total Open
Publications
97
Total
Citations
12K
Open Access
Percentage
64%
Total
Publications
152
Total Open
Publications
97
Total
Citations
12K
Breakdown
Publisher Open
12%
Both
38%
Other Platform Open
13%
Closed
37%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
27
Hybrid 19%
14
No Guarantees 45%
34
Other Platform Open
Domain 69%
54
Other Internet 24%
19
Institution 10%
8
Preprint 6%
5
Public 3%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 54 |
DOI | Other Internet | 19 |
bioRxiv | Preprint | 5 |
Europe PMC | Domain | 4 |
Royal Netherlands Academy of Arts and Sciences | Institution | 2 |
Harvard University | Institution | 2 |
Figshare | Public | 2 |
University of Turin | Institution | 1 |
University of Milan | Institution | 1 |
University of Dundee | Institution | 1 |